Clinical Trial Update: Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating pazopanib hydrochloride versus placebo in non-small cell lung cancer patients who have received first-line chemotherapy was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 2, Phase 3 | Status: TERMINATED